Vistagen Therapeutics, Inc. (VTGN)
NASDAQ: VTGN · Real-Time Price · USD
2.930
+0.070 (2.45%)
At close: Aug 13, 2025, 4:00 PM
2.830
-0.100 (-3.41%)
Pre-market: Aug 14, 2025, 9:25 AM EDT
Vistagen Therapeutics Employees
As of March 31, 2025, Vistagen Therapeutics had 57 total employees, including 56 full-time and 1 part-time employees. The number of employees increased by 17 or 42.50% compared to the previous year.
Employees
57
Change (1Y)
17
Growth (1Y)
42.50%
Revenue / Employee
$11,333
Profits / Employee
-$978,596
Market Cap
89.89M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
VTGN News
- 5 days ago - Vistagen Therapeutics, Inc. (VTGN) Q1 2026 Earnings Call Transcript - Seeking Alpha
- 6 days ago - Vistagen Reports Fiscal Year 2026 First Quarter Financial Results and Corporate Update - Business Wire
- 14 days ago - Vistagen to Report Fiscal Year 2026 First Quarter Results and Host Corporate Update Conference Call on August 7, 2025 - Business Wire
- 21 days ago - Vistagen to Present at the BTIG Virtual Biotechnology Conference - Business Wire
- 4 weeks ago - Vistagen Honored for Outstanding Workplace Culture and Mental Health Leadership - Business Wire
- 7 weeks ago - Vistagen Appoints Elissa Cote as Chief Corporate Development Officer - Business Wire
- 2 months ago - Vistagen Therapeutics, Inc. (VTGN) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Vistagen Reports Fiscal Year 2025 Financial Results and Provides Corporate Update - Business Wire